DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Solomon BJ, Mok T, Kim DW. et al.
First-line crizotinib versus chemotherapy in ALK-positive lung cancer.
The New England journal of medicine 2014;
371: 2167-2177
We do not assume any responsibility for the contents of the web pages of other providers.